Recent discussions surrounding public health measures have highlighted several claims regarding the MFlusiva flu vaccine and the use of ivermectin in relation to COVID-19. Information shared on social media platforms has been flagged for containing unsubstantiated details. Specifically, a post circulated by Aivis Vasiļevskis on Facebook alleged that the U.S.
Food and Drug Administration (FDA) had confirmed the MFlusiva, an mRNA-based flu vaccine, for seniors over 50. This post, which was shared widely, also contained misinformation concerning the antiparasitic drug ivermectin. However, sources indicate that these claims are inaccurate.
There is conflicting information circulating regarding the MFlusiva vaccine’s approval status and efficacy against COVID. Some reports suggest the vaccine has not successfully passed all necessary clinical trials. Furthermore, multiple statements within the provided text contradict each other regarding the vaccine’s effectiveness against COVID, and assert that ivermectin does not treat COVID-19.
Public health authorities have addressed these circulating rumors, clarifying that the purported FDA confirmation of the MFlusiva vaccine is unfounded. The dissemination of such unverified information regarding both the flu vaccine and treatments for COVID-19 underscores the need for reliance on official medical channels for accurate guidance.
Topics: #flu #vaccine #covid
Recent discussions regarding the mRNS flu vaccine and the use of ivermectin for COVID-19 have brought several claims to light. Information shared on social media platforms has been identified as conta
What are the current, scientifically verified recommendations regarding the mRNS flu vaccine and ivermectin for COVID-19?